Structure Of Azacitidine (E1ef6b99 Ee6e 4387 B3d2 E74e35af5661 01)
Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 83774-102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 83774-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pilnova Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Kaplan-meier Curve Of Time To Death From Any Cause: (intent-to-treat Population) (E1ef6b99 Ee6e 4387 B3d2 E74e35af5661 02)
The text provides information on a survival analysis comparing two treatments - Aza and CCR. The Log-Rank test showed a statistically significant difference in survival between the two groups (p=0.0001). The Hazard Ratio (HR) was calculated at 0.58 with a 95% confidence interval of 0.43 to 0.77. The number of deaths recorded were 82 for Aza and 113 for CCR. The data also includes a graph showing the proportion surviving over time in months for each treatment group. This analysis is valuable for evaluating the effectiveness of the treatments in terms of survival outcomes.*
Azacitidine For Injection 100mg/vial, Vial Label (E1ef6b99 Ee6e 4387 B3d2 E74e35af5661 03)
This is a description of a sterile single-dose vial containing azacitidine 100 mg and mannitol 100 mg. It provides information about dosing, administration, storage conditions, and the manufacturer details. The vial is intended for subcutaneous and intravenous use only, with clear instructions to discard the unused portion and keep it out of reach of children. The product is distributed by Pilnova Pharma Inc. in Hillsborough, NJ.*
Azacitidine For Injection 100mg/vial Carton Label (E1ef6b99 Ee6e 4387 B3d2 E74e35af5661 04)
This is a description of a medication named Azacitidine for Injection, available in a single-dose vial containing 100 mg of azacitidine and 100 mg of mannitol. It is intended for subcutaneous and intravenous use only. The product should be stored at 25°C (77°F) with excursions permitted. The vial should be discarded if unused and kept out of reach of children. Detailed prescribing information for dosing and administration should be consulted. The medication is manufactured by Shilpa Medicare Limited in India and distributed by Pilnova Pharma Inc in the United States. The text also mentions storage conditions, batch code, and expiry date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
